{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:22:20Z","timestamp":1764588140532,"version":"3.40.5"},"reference-count":20,"publisher":"Informa UK Limited","issue":"17","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.2217\/fmb-2020-0089","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T12:52:00Z","timestamp":1605876720000},"page":"1607-1609","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Overcoming Drug resistance in TB: An Update"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-7686","authenticated-orcid":false,"given":"Sara","family":"Consalvi","sequence":"first","affiliation":[{"name":"Department of Chemistry & Technology of Drugs,Sapienza University of Rome,\rPiazzale A Moro 5,\r00185\rRome,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7466-8861","authenticated-orcid":false,"given":"Giovanna","family":"Poce","sequence":"additional","affiliation":[{"name":"Department of Chemistry & Technology of Drugs,Sapienza University of Rome,\rPiazzale A Moro 5,\r00185\rRome,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7967-091X","authenticated-orcid":false,"given":"Cristina","family":"Scarpecci","sequence":"additional","affiliation":[{"name":"Department of Chemistry & Technology of Drugs,Sapienza University of Rome,\rPiazzale A Moro 5,\r00185\rRome,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-807X","authenticated-orcid":false,"given":"Mariangela","family":"Biava","sequence":"additional","affiliation":[{"name":"Department of Chemistry & Technology of Drugs,Sapienza University of Rome,\rPiazzale A Moro 5,\r00185\rRome,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"World Health Organization . Global tuberculosis report. Licence: CC BY-NC-SA 3.0 IGOGeneva (2020). http:\/\/www.who.int\/tb\/publications\/global_report\/en\/"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0959"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(16)30035-4"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2014.05.023"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60570-0"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6696"},{"issue":"4","key":"e_1_3_2_8_1","first-page":"418","article-title":"Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance","volume":"62","author":"Cegielski JP","year":"2016","unstructured":"Cegielski JP , KurbatovaE , vander Walt Met al. Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance. Clin. Infect. Dis.62(4), 418\u2013430 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.12513"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705385114"},{"issue":"641","key":"e_1_3_2_11_1","first-page":"1","article-title":"High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo","volume":"6","author":"Hu Y","year":"2015","unstructured":"Hu Y , LiuA , Ortega-MuroFet al. High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo. Front. Microbiol.6(641), 1\u201310 (2015).","journal-title":"Front. Microbiol."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003023"},{"key":"e_1_3_2_13_1","unstructured":"World Health Organization . Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. (2013). https:\/\/apps.who.int\/iris\/handle\/10665\/112472"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0217"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.12842.1"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0715"},{"key":"e_1_3_2_17_1","unstructured":"World Health Organization . WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis. Licence: CC BY-NC-SA 3.0 IGOGeneva (2018). http:\/\/www.who.int\/tb\/publications\/2018\/WHO_guidelines_isoniazid_resistant_TB\/en\/"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30078-X"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201909-1874ST"},{"key":"e_1_3_2_20_1","unstructured":"World Health Organization . Implementing the end TB strategy: the essentials (2015). http:\/\/www.who.int\/tb\/publications\/2015\/The_Essentials_to_End_TB\/en\/"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-8035-z"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2020-0089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:04Z","timestamp":1719124804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2020-0089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":20,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.2217\/fmb-2020-0089"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2020-0089","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"type":"print","value":"1746-0913"},{"type":"electronic","value":"1746-0921"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}